BOLT · Bolt Biotherapeutics Inc
United States · RS rating 27 · As of 2026-10-14
| Price | 3.98 USD |
|---|---|
| 1-day change | -7.1% |
| RS rating (overall / 1M / 3M / 12M) | 27 / 58 / 43 / 21 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 18 / 19 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -3.2% |
| Sales growth Q/Q | +15.3% |
| Distance from 52-week high | +43.9% |
| Market cap (USD) | $9.2M |